Activation of a cryptic splice donor in human immunodeficiency virus type-1

Journal of Biomedical Science

Volumn 6, Issue 1, 1999, Pages 45-52

  Borg, Keith M ^a   Favaro, Justin P ^a   Arrigo, Salvatore J ^a   Schmidt, Michael ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cryptic splice donor; HIV 1; Rev; Splicing

Indexed keywords

REV PROTEIN; VIRUS RNA;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DNA SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; REPRESSOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032977206     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02256423     Document Type: Article

References (39)

1. Arrigo SJ, Chen ISY. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu-2 RNAs. Genes Dev 5:808-819;1991.
2. Arrigo SJ, Weitsman S, Rosenblatt JD, Chen IS. Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method. J Virol 63: 4875-4881;1989.
3. Arrigo SJ, Weitsman S, Zack JA, Chen IS. Characterization and expression of novel singly spliced RNA species of human immunodeficiency virus type 1. J Virol 64:4585-4588; 1990.
4. Barksdale SK, Baker CC. The human immunodeficiency virus type 1 Rev protein and the Rev-responsive element counteract the effect of an inhibitory 5′ splice site in a 3′ untranslated region. Mol Cell Biol 15:2962-2971; 1995.
5. Borg KT, Favaro JP, Arrigo SJ. Involvement of human immunodeficiency virus type-1 splice sites in the cytoplasmic accumulation of viral RNAs. Virology 236:95-103;1997.
6. Brighty DW, Rosenberg M. A cis-acting repressive sequence that overlaps the Rev-responsive element of human immunodeficiency virus type 1 regulates nuclear retention of env mRNAs independently of known splice signals. Proc Natl Acad Sci USA 91:8314-8318;1994.
7. Campbell LH, Borg KT, Arrigo SJ. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Revresponsive element. Virology 219:423-431; 1996.
8. Chang DD, Sharp PA. Regulation by HIV Rev depends upon recognition of splice sites. Cell 59:789-795;1989.
9. Churchill MJ, Moore JL, Rosenberg M, Brighty DW. The rev-responsive element negatively regulates human immunodeficiency virus type 1 env mRNA expression in primate cells. J Virol 70:5786-5790;1996.
10. Cochrane AW, Jones KS, Beidas S, Dillon PJ, Skalka AM, Rosen CA. Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J Virol 65:5305-5313; 1991.
11. Dagostino DM, Felber BK, Harrison JE, Pavlakis GN. The Rev protein of human immunodeficiency virus type-1 promotes polysomal association and translation of gag/pol and vpu/env messenger RNAs. Mol Cell Biol 12:1375-1386; 1992.
12. Dayton AI. The Rev axis of HIV-1 and its associated host cofactors: A viral window onto the workings of eukaryotic posttranscriptional RNA processing. J Biomed Sci 3:69-77;1996.
13. Favaro JP, Arrigo SJ. Characterization of Rev function using subgenomic and genomic constructs in T and COS cells. Virology 228:29-38; 1997.
14. Felber BK, Hadzopoulou CM, Cladaras C, Copeland T, Pavlakis GN. Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc Natl Acad Sci USA 86:1495-1499;1989.
15. Finberg RW, Wahl SM, Allen JB, Soman G, Strom TB, Murphy JR, Nichols JC. Selective elimination of HIV-1-infected cells with an interleukin-2 receptor-specific cytotoxin. Science 252:1703-1705;1991.
16. Fischer U, Huber J, Boelens WC, Mattaj IW, Luhrmann R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82:475-483;1995.
17. Gatlin J, Campbell LH, Schmidt MG, Arrigo SJ. Direct-rapid (DR) mutagenesis of large plasmids using PCR. Biotechniques 19:559-564;1995.
18. Hadzopoulou CM, Felber BK, Cladaras C, Athanassopoulos A, Tse A, Pavlakis GN. The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J Virol 63:1265-1274;1989.
19. Hammarskjold ML, Heimer J, Hammarskjold B, Sangwan I, Albert L, Rekosh D. Regulation of human immunodeficiency virus env expression by the rev gene product. J Virol 63:1959-1966;1989.
20. Hammarskjold ML, Li H, Rekosh D, Prasad S. Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intron. J Virol 68:951-958;1994.
21. Huffman KM, Arrigo SJ. Identification of cis-acting repressor activity within human immunodeficiency virus type-1 protease. Virology 234:253-260;1997.
22. Katz RA. Control of retroviral RNA splicing through maintenance of suboptimal processing signals. Mol Cell Biol 10:696-704;1990.
23. Lawrence JB, Cochrane AW, Johnson CV, Perkins A, Rosen CA. The HIV-1 Rev protein: a model system for coupled RNA transport and translation. New Biol 3:1220-1232;1991.
24. Lewis N, Williams J, Rekosh D, Hammarskjold ML. Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins. J Virol 64:1690-1697;1990.
25. Lu XB, Heimer J, Rekosh D, Hammarskjold ML, U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc Natl Acad Sci USA 87:7598-7602;1990.
26. Maldarelli F, Martim MA, Strebel K: Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type-1 RNA - novel level of gene regulation. J Virol 65:5732-5743;1991.
27. Malim MH, Hauber J, Fenrick R, Cullen BR. Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature 335:181-183;1988.
28. Malim MH, Hauber J, Le SY, Maizel JV, Cullen BR. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338:254-257;1989.
29. Mikaelian I, Krieg M, Gait MJ, Karn J. Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive RNAs. J Mol Biol 257:246-264; 1996.
30. Mount SM. A catalogue of splice junction sequences. Nucleic Acids Res 10:459-472;1982.
31. Nasioulas G, Zolotukhin AS, Tabernero C, Solomin L, Cunningham CP, Pavlakis GN, Felber BK. Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. J Virol 68:2986-2993;1994.
32. O'Reilly MM, McNally MT, Beemon KL. Two strong 5′ splice sites and competing, suboptimal 3′ splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA. Virology 213:373-385;1995.
33. Purcell DF, Martin MA. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol 67:6365-6378;1993.
34. Rosen CA, Terwilliger E, Dayton A, Sodroski JG, Haseltine WA. Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc Natl Acad Sci USA 85:2071-2075;1988.
35. Schwartz S, Campbell M, Nasioulas G, Harrison J, Felber BK, Pavlakis GN. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J Virol 66: 7176-7182;1992.
36. Schwartz S, Felber BK, Pavlakis GN. Distinct RNA sequences in the gag region of human immunodeficiency virus type-1 decrease RNA stability and inhibit expression in the absence of Rev protein. J Virol 66:150-159;1992.
37. Schwartz S, Felber BK, Pavlakis GN. Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type-1 mRNAs. Mol Cell Biol 12:207-219; 1992.
38. Sodroski J, Goh WC, Rosen C, Dayton A, Terwilliger E, Haseltine W. A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature 321:412-417; 1986.
39. Tan W, Schalling M, Zhao C, Luukkonen M, Nilsson M, Fenyo EM, Pavlakis GN, Schwartz S. Inhibitory activity of the equine infectious anemia virus major 5′ splice site in the absence of Rev. J Virol 70:3645-3658;1996.